Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Over 250,000 cases of shredded cheese recalled over possible metal fragments - 2Remain Cool and Solid: Top Summer Food sources for 2024
- 3Space Condos to Lift Your Metropolitan Living
- 45 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
- 5Jersey's wellbeing score is below UK and France
- New hybrid mpox strain discovered in UK after US reports local spread
- Netflix’s Price Hikes Just Got Rejected by an Italian Court. Here’s Why It Matters Everywhere
- No respite for German economy as experts slash forecast over Iran war
- Doritos and Cheetos debut 'NKD' options, without artificial colors or flavors
- Tesla Stock Hasn’t Looked This Cheap in a While
- Hostages as leverage: Iran's secret demand aimed at crippling Israel's agriculture
- Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny
- IDF struck Iran's largest petrochemical plant, second facility hit in two days, Katz confirms
- Divorce filings, feuds and legal trouble: The 'Mormon Wives' drama keeps piling up
